Prudential Financial Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

$70.5 Billion
Q1 2024

A detailed history of Prudential Financial Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 11,860 shares of ARWR stock, worth $297,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,860

Previous 13,256 10.53%

Holding current value

$297,330

Previous $405,000 16.3%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$27.21 - $39.48 $37,985 - $55,114	-1,396 Reduced 10.53%	11,860 $339,000
Q4 2023 Feb 13, 2024	BUY	$21.2 - $31.03 $6,953 - $10,177	328 Added 2.54%	13,256 $405,000
Q3 2023 Nov 13, 2023	BUY	$26.2 - $36.08 $19,440 - $26,771	742 Added 6.09%	12,928 $347,000
Q2 2023 Aug 11, 2023	SELL	$25.16 - $41.38 $1,107 - $1,820	-44 Reduced 0.36%	12,186 $434,000
Q1 2023 May 12, 2023	SELL	$23.68 - $38.51 $4,901 - $7,971	-207 Reduced 1.66%	12,230 $310,000

Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $2,884 - $4,177	-103 Reduced 0.82%	12,437 $0
Q3 2022 Nov 04, 2022	BUY	$29.63 - $48.31 $1,096 - $1,787	37 Added 0.3%	12,540 $417,000
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $2.02 Million - $3.68 Million	-72,696 Reduced 85.32%	12,503 $432,000
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $3.25 Million - $5.74 Million	-82,026 Reduced 49.05%	85,199 $3.92 Million
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $3.03 Million - $4.3 Million	-52,088 Reduced 23.75%	167,225 $11.1 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $9.01 Million - $13.1 Million	154,282 Added 237.24%	219,313 $13.7 Million
Q2 2021 Aug 16, 2021	SELL	$62.15 - $90.32 $252,018 - $366,247	-4,055 Reduced 5.87%	65,031 $5.39 Million
Q1 2021 May 12, 2021	BUY	$61.35 - $90.47 $2.99 Million - $4.41 Million	48,739 Added 239.54%	69,086 $4.58 Million
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $842,395 - $1.64 Million	19,224 Added 1711.84%	20,347 $1.56 Million
Q3 2020 Aug 05, 2021	SELL	$33.21 - $51.27 $594,425 - $917,681	-17,899 Reduced 94.1%	1,123 $48,000
Q3 2020 Nov 16, 2020	BUY	$33.21 - $51.27 $626,307 - $966,900	18,859 Added 11569.94%	19,022 $819,000
Q2 2020 Aug 05, 2021	SELL	$26.12 - $43.27 $4.89 Million - $8.11 Million	-187,395 Reduced 99.91%	163 $7,000
Q2 2020 Aug 12, 2020	BUY	$26.12 - $43.27 $4.9 Million - $8.11 Million	187,465 Added 201575.27%	187,558 $8.1 Million
Q1 2020 Aug 05, 2021	SELL	$20.56 - $63.12 $4.8 Million - $14.7 Million	-233,569 Reduced 99.96%	93 $3,000
Q1 2020 May 12, 2020	BUY	$20.56 - $63.12 $4.8 Million - $14.7 Million	233,566 Added 243297.92%	233,662 $6.72 Million
Q4 2019 Aug 05, 2021	SELL	$28.14 - $73.01 $4.53 Million - $11.8 Million	-161,138 Reduced 99.94%	96 $6,000
Q4 2019 Feb 11, 2020	BUY	$28.14 - $73.01 $27,070 - $70,235	962 Added 0.6%	161,234 $10.2 Million
Q3 2019 Nov 13, 2019	SELL	$26.26 - $34.86 $185,001 - $245,588	-7,045 Reduced 4.21%	160,272 $4.52 Million
Q2 2019 Aug 08, 2019	BUY	$17.43 - $28.82 $2.33 Million - $3.85 Million	133,757 Added 398.56%	167,317 $0
Q1 2019 May 15, 2019	BUY	$12.05 - $20.18 $404,398 - $677,240	33,560 New	33,560 $0

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.65B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Arrowhead Pharmaceuticals, Inc. Transaction History